Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis

Pediatric Transplantation

Volumn 10, Issue 7, 2006, Pages 816-821

  Kamel, M H ^a   Mohan, P ^a   Conlon, P J ^a   Little, D M ^a   O'Kelly, P ^a   Hickey, D P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Pediatric; RATG; Thrombocytopenia; Thrombosis; Transplantation

Indexed keywords

ACICLOVIR; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; PREDNISOLONE; RABBIT ANTITHYMOCYTE GLOBULIN; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT THROMBOSIS; HUMAN; IMMUNOTHERAPY; INFECTIOUS COMPLICATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; RISK FACTOR; THROMBOCYTE COUNT; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ANIMALS; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; RABBITS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33749567154     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00533.x     Document Type: Article

References (22)

1. SINGH A, STABLEIN D, TEJANI A. Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997: 63: 1263-1267.
2. EL-SABROUT R, BUCH K. Outcome of renal transplants from pediatric donors < 5 yr of age. Clin Transplant 2005: 19: 316-320.
3. MCDONALD RA, SMITH JM, STABLEIN D, HARMON WE. Pre-transplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report. Pediatr Transplant 2003: 7: 204-208.
4. NASHAN B. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review. BioDrugs 2005: 19: 39-46.
5. FULLARD JF. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des 2004: 10: 1567-1576.
6. PALLESCHI J, NOVICK AC, BRAUN WE, MAGNUSSON MO. Vascular complications of renal transplantation. Urology 1980: 16: 61-67.
7. NEILD GH, REUBEN R, HARTLEY RB, CAMERON JS. Glomerular thrombi in renal allografts associated with cyclosporin treatment. J Clin Pathol 1985: 38: 253-258.
8. ISMAIL H, KALICINSKI P, DREWNIAK T, et al. Primary vascular thrombosis after renal transplantation in children. Pediatr Transplant 1997: 1: 43-47.
9. KIM MS, STABLEIN D, HARMON WE. Renal transplantation in children with congenital nephrotic syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998: 4: 305-308.
10. MELAMED ML, KIM HS, JAAR BG, MOLMENTI E, ATTA MG, SAMANIEGO MD. Combined percutaneous mechanical and chemical thrombectomy for renal vein thrombosis in kidney transplant recipients. Am J Transplant 2005: 5: 621-626.
11. ROSENBERG JC, LEKAS N, LYSZ K, MORRELL R. Effect of antithymocyte globulin and other immune reactants on human platelets. Surgery 1975: 77: 520-529.
12. MEE AD, EVANS DB. Antilymphocyte-serum preparations in treatment of renal-allograft rejection. Lancet 1970: 2: 16-19.
13. INBAL A, LUBETSKY A, SHIMONI A, et al. Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation. Bone Marrow Transplant 2004: 34: 459-463.
14. PIHUSCH R, HOHNBERG B, SALAT C, PIHUSCH M, HILLER E, KOLB HJ. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation. Ann Hematol 2002: 81: 454-461.
15. ABRAMOWICZ D, PRADIER O, MARCHANT A, et al. Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet 1992: 339: 777-778.
16. THIBAUDIN D, ALAMARTINE E, DE FILIPPIS JP, DIAB N, LAURENT B, BERTHOUX F. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. Nephrol Dial Transplant 1998: 13: 711-715.
17. ROBERTSON AJ, NARGUND V, GRAY DW, MORRIS PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrol Dial Transplant 2000: 15: 1865-1868.
18. DI FILIPPO S. Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation. Pediatr Transplant 2005: 3: 373-380.
19. DHARNIDHARKA VR, STABLEIN DM, HARMON WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant 2004: 4: 384-389.
20. SWINNEN LJ, COSTANZO-NORDIN MR, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990: 323: 1723-1728.
21. DARENKOV IA, MARCARELLI MA, BASADONNA GP, et al. Reduced incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 1997: 64: 848-852.
22. DHARNIDHARKA VR, STEVENS G. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation. Pediatr Transplant 2005: 5: 622-626.